A rapid decline in the use of hormone drugs in 2002 probably explains the drop in breast cancer cases in recent years, according to a University of California study.

The findings also suggest that women who stop taking hormone drugs may be able to reduce their risk of breast cancer quickly, researchers said. The study, by researchers from the University of California, San Francisco, is published online in today's Journal of the National Cancer Institute.

Millions of menopausal women stopped taking hormone replacement drugs, used to treat symptoms such as hot flashes, after a study linked Wyeth's Prempro to heart disease and cancer. Hormone drugs contain estrogen, which is implicated in breast cancer risk. The University of California study found annual rates of estrogen-fueled cancers fell 13 percent a year from 2001 to 2003, while overall breast cancer rates fell 5 percent.

"There is clearly a causal link," said Karla Kerlikowske, professor of medicine at the University of California in San Francisco and the studies lead author. "For people who stop taking hormones, their risk decreases fairly quickly. That's a positive, exciting message."

The study adds to similar findings published in April by a group from University of Texas M.D. Anderson Cancer Center in Houston, which showed a 6.7 percent decline in the number of women diagnosed with breast cancer in 2003.

The University of California study found that use of hormone therapy declined 7 percent a year from 2000 to 2002 and then plunged 34 percent from 2002 to 2003.



We're here to help!

We live by our creed of "helping those who need it most" and have helped thousands of clients get the justice they desperately needed and deserved. If you feel you have a case or just have questions please contact us for a free consultation. There is no risk and no fees unless we win for you.

Fields marked    may be required for submission.
  1. I'm an attorney

Beasley Allen secures $5.1 million verdict for woman...

MONTGOMERY, ALA. (September 7, 2012) – A federal jury in Salt Lake City, Utah awarded $5.1 million to...

Evidence indicates link between combination HRT and...

For years, drug companies touted the benefits of HRT. Marketing campaigns for medications like Premarin,...

Wyeth Pharmaceuticals settles HRT cases following jury...

A Philadelphia, Pa., jury awarded $72.6 million to three plaintiffs in a Hormone Replacement Therapy...

Beasley Allen attorney Ted Meadows selected to help...

Beasley, Allen, Crow, Methvin, Portis & Miles, P.C., attorney Ted Meadows, who practices in the firm’s...

Verdict history shows juries find Wyeth downplayed...

Recently, the Pennsylvania Appellate Court affirmed a $1.5 million compensatory and $8.6 million...

Study reveals HRT even deadlier than previously thought

Women who used hormone replacement therapy (HRT) not only put themselves at risk for breast cancer,...

Number one firm

I really appreciate the law firm, they look into every detail, they review everything with you not just once but several times to make sure everything is correct. They are a very good law firm and I would highly recommend them. They'll always call you back when you call with questions. They're number one in my book.

—Melva